Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer

Fig. 5

Validation of our discovery in a clinical in-house cohort. A Kaplan–Meier curves of RFS according to the CRRS. B Univariate and multivariate Cox regression analysis of the risk score. C Time-dependent ROC analysis for predicting RFS at 1–5 years. D Calibration plots for comparing the actual probabilities and the predicted probabilities of RFS at 1–5 years

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us